LOS ANGELES CAPITAL MANAGEMENT LLC - MERIDIAN BIOSCIENCE INC ownership

MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 180 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of MERIDIAN BIOSCIENCE INC
ValueSharesWeighting
Q2 2022$488,000
-63.5%
16,034
-68.9%
0.00%
-60.0%
Q1 2022$1,338,000
+12.5%
51,531
-11.6%
0.01%
+25.0%
Q4 2021$1,189,000
-37.0%
58,271
-40.6%
0.00%
-55.6%
Q3 2021$1,887,000
-17.4%
98,061
-4.8%
0.01%
-10.0%
Q2 2021$2,285,000
+67.5%
103,000
+98.2%
0.01%
+66.7%
Q1 2021$1,364,000
+65.1%
51,974
+17.5%
0.01%
+50.0%
Q4 2020$826,000
+3.4%
44,215
-6.0%
0.00%0.0%
Q3 2020$799,000
-63.6%
47,055
-50.0%
0.00%
-63.6%
Q2 2020$2,194,000
+252.2%
94,196
+27.1%
0.01%
+175.0%
Q1 2020$623,000
-59.7%
74,119
-15.5%
0.00%
-55.6%
Q1 2019$1,545,000
-53.8%
87,715
-54.5%
0.01%
-57.1%
Q4 2018$3,345,000
+86.0%
192,705
+59.7%
0.02%
+133.3%
Q3 2018$1,798,000
+35.1%
120,669
+44.1%
0.01%
+28.6%
Q2 2018$1,331,000
+11.9%
83,7170.0%0.01%0.0%
Q1 2018$1,189,000
-37.0%
83,717
-37.9%
0.01%
-30.0%
Q4 2017$1,886,000
+50.9%
134,712
+54.1%
0.01%
+42.9%
Q3 2017$1,250,000
+41.1%
87,401
+55.3%
0.01%
+16.7%
Q2 2017$886,000
+2.4%
56,261
-10.3%
0.01%0.0%
Q1 2017$865,000
-9.2%
62,701
+16.4%
0.01%
-14.3%
Q4 2016$953,000
-8.3%
53,8700.0%0.01%
-22.2%
Q3 2016$1,039,000
+13.2%
53,870
+14.5%
0.01%
+12.5%
Q2 2016$918,00047,0600.01%
Other shareholders
MERIDIAN BIOSCIENCE INC shareholders Q3 2021
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 115,571$3,034,0002.64%
Acuitas Investments, LLC 160,046$4,201,0002.41%
HUSSMAN STRATEGIC ADVISORS, INC. 144,000$3,780,0000.78%
GLOBEFLEX CAPITAL L P 158,664$4,165,0000.76%
CLARK ESTATES INC/NY 220,000$5,775,0000.74%
SYSTEMATIC FINANCIAL MANAGEMENT LP 721,176$18,931,0000.69%
EARNEST PARTNERS LLC 4,341,834$113,973,0000.68%
MOODY ALDRICH PARTNERS LLC 138,844$3,645,0000.53%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 889,269$23,343,0000.49%
Phocas Financial Corp. 134,740$3,537,0000.47%
View complete list of MERIDIAN BIOSCIENCE INC shareholders